281 Intravenous immunoglobulin, high-dose corticosteroids, and infliximab in the treatment of refractory Kawasaki disease: A retrospective review

Saturday, April 25, 2009
Amanda J. Worshum, Student , Samford University, Birmingham, AL
Paula Thompson, M.S., Pharm.D., BCPS , Samford University, Birmingham, AL
Mary Worthington, Pharm.D., BCPS , Samford University, Birmingham, AL
Sean King, M.S., Ph.D. , Samford University, Birmingham, AL
Walter H. Johnson Jr., M.D. , University of Alabama at Birmingham, Birmingham, AL